📰 3 sources covering this story
AstraZeneca stock dives 9% after heart drug trial misses target
Compare how each outlet is covering it — and rate the sources you trust.
STAT News44 mins ago
STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug
Financial Times2 hrs ago
AstraZeneca shares slide after heart treatment disappoints in trial